Healthtech & Wellness VC Funds

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

HV Ventures, also known as Lighthouse Ventures, is a venture capital firm based in Prague, Czech Republic, that focuses on early-stage investments. The firm is particularly active in the Central and Eastern European (CEE) region, supporting startups in sectors like financial services, logistics, and enterprise technology. Notable investments include 4Trans, Persoo, and AhoyConnect. LHV Ventures typically invests in seed and Series A rounds, with initial investments ranging from €200,000 to €3 million. They provide not only financial backing but also professional support through their extensive network and expertise in entrepreneurship, startup mentoring, and mergers and acquisitions. The firm is highly active in the local startup ecosystem, often co-investing with other prominent funds and leveraging support from initiatives like the Czech ESIF Fund of Funds to nurture promising startups. Key team members include Managing Partner Michal Zálešák, who brings a wealth of experience and leadership to the firm. LHV Ventures' approach emphasizes deep involvement with portfolio companies, helping them navigate challenges and scale effectively. Entrepreneurs looking to pitch to LHV Ventures should focus on demonstrating strong market potential and innovative solutions, particularly those that can scale globally from their base in the CEE region. The firm values thorough preparation and a clear understanding of the market dynamics. Overall, LHV Ventures is committed to fostering growth in the CEE startup ecosystem through strategic investments and active engagement with founders and their teams.

The Lightsmith Group is a private equity firm that specializes in investing in growth-stage companies focused on climate resilience and adaptation. Their inaugural fund, Lightsmith Climate Resilience Partners, closed with $186 million in commitments, making it the first private equity fund specifically aimed at climate resilience technologies. The firm targets sectors such as water efficiency, smart agriculture, geospatial intelligence, and catastrophe risk management. Founded by Jay Koh and Sanjay Wagle, Lightsmith Group applies its investment expertise to help scale companies that offer solutions to the growing physical impacts of climate change, including droughts, agricultural stress, and supply chain disruptions. Notable investments include SOURCE Global, a water harvesting company, and WayCool Foods, which optimizes the food supply chain in India. They focus on delivering both financial returns and measurable social and environmental impacts. The firm’s investment strategy is supported by leading global investors, including the Green Climate Fund, European Investment Bank, and The Rockefeller Foundation. By leveraging its global network, Lightsmith helps companies expand internationally, particularly in emerging markets​.

Lightrock is a global private equity firm that focuses on investing in sustainable businesses led by purpose-driven entrepreneurs. The firm aims to drive systemic change at scale through innovation, aligning its investments with impact themes such as "people," "planet," and "productivity/tech for good." Founded under the umbrella of LGT, Lightrock is committed to creating positive societal and environmental returns alongside financial gains​. Lightrock's diverse portfolio includes over 60 high-growth companies worldwide. Notable investments include Infarm, a rapidly growing urban farming network; PharmEasy, a leading omni-channel healthcare platform in India; and M-Kopa, a pioneer in pay-as-you-go solar energy services for off-grid customers in East Africa​. The firm actively supports its portfolio companies, often taking board positions to guide their dynamic growth and expansion. Headquartered in London, Lightrock operates globally with a team of more than 55 investment professionals across four continents, encompassing extensive experience in impact investing, leadership, and entrepreneurship. The firm is led by CEO Pal Erik Sjatil, the former Managing Partner of McKinsey & Company Europe​.

Lightship Capital is a venture capital firm with a distinct mission to empower and invest in underrepresented entrepreneurs. Based in Cincinnati, Ohio, Lightship specifically targets startups led by BIPOC (Black, Indigenous, and People of Color), women, LGBTQ+ individuals, and people with disabilities. Their investments span across the Midwest and South, purposefully avoiding oversaturated markets like Silicon Valley, New York, and Boston. The fund’s industry focus includes sectors such as Consumer Packaged Goods (CPG), E-commerce, Sustainability, Artificial Intelligence (AI), and Health Tech. Notable investments include companies like Healthy Roots Dolls, Vyrill, and ProovTest, which exemplify their commitment to supporting high-growth, impactful businesses. Lightship typically invests at the pre-seed to Series A stages, with an average check size of around $2 million. They are known for actively leading rounds and bringing in Executives-in-Residence with experience from major corporations like Procter & Gamble and Cincinnati Children’s Hospital to support portfolio companies. The firm is led by General Partners Candice Matthews Brackeen and Brian Brackeen, who bring extensive experience in fund management and technology. Their approach to sourcing deals emphasizes building relationships within underrepresented communities and fostering long-term success through hands-on mentorship and strategic guidance. For startups looking to connect with Lightship, aligning with their mission to drive systemic change in the venture capital landscape is crucial.

Lightspeed Venture Partners, founded in 2000, is a prominent global venture capital firm based in Menlo Park, California. The firm specializes in multi-stage investments, supporting companies from seed to growth stages. Lightspeed's investment focus spans several sectors, including enterprise, consumer, fintech, and healthcare. Some of Lightspeed's notable investments include Snapchat, Affirm, and Rubrik. Snapchat, a popular social media platform, went public in 2017, marking a significant success for the firm. Affirm, a financial technology company, also achieved a successful IPO in 2021. Rubrik, a leader in cloud data management, is another key company in their portfolio that highlights Lightspeed's focus on disruptive technology. Lightspeed Venture Partners has raised substantial funds over the years to support its diverse portfolio. In 2020, the firm raised $4.2 billion across three funds: an early-stage venture fund, a growth fund for later-stage investments, and an opportunity fund for doubling down on successful investments. The firm's philosophy centers on deep commitment and collaboration with founders, providing not just capital but also strategic guidance and support to help build enduring companies. With a global presence and a history of backing innovative companies, Lightspeed continues to be a key player in the venture capital landscape.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Lilly Asia Ventures (LAV) is a Shanghai-based biomedical venture capital firm founded in 2008 as the corporate venture arm of Eli Lilly before becoming fully independent in 2011, when it began raising third-party capital with Fund III. Headquartered in Shanghai with offices in Hong Kong and Palo Alto, LAV now manages approximately $4.5 billion in assets across seven funds. Fund VI closed at $1.35 billion in 2021, followed by Fund VII, which reached its $700 million hard cap. Managing Partner Yi Shi has led the firm since its founding, guiding its evolution from a corporate subsidiary into one of Asia's largest independent biomedical venture franchises. LAV invests globally across the full biomedical spectrum — from seed stage to publicly traded companies — in biopharmaceuticals, human therapeutics, medical devices, and diagnostics. The firm leads rounds and has made 326 total investments, achieving 54 portfolio exits. Among the most notable are NASDAQ IPOs for ArriVent, which reached a $575 million market cap in January 2024, and Alector, with a $1.3 billion market cap. Insilico Medicine became LAV's latest unicorn in 2025, exiting in December 2025 just three years after LAV's initial investment. Recent 2025 deals include StairMed Technology, Rona Therapeutics, EnChannel Medical, and a co-led $100 million Series C for Pulnova Medical. LAV's stated vision is to be the trusted partner for exceptional entrepreneurs seeking smart capital to build companies developing breakthrough health products. The firm brings deep scientific networks across Asia and North America, providing portfolio companies with access to clinical development expertise, regulatory knowledge, and global licensing relationships that are particularly valuable when bridging Asian and Western healthcare markets.

Lilly Ventures is the corporate venture capital arm of Eli Lilly and Company, based in Indianapolis, Indiana, and responsible for life science investing across North America and Europe. The fund manages approximately $200 million and operates as a therapeutically agnostic investor, backing companies from early to expansion stage across biotechnology, healthcare IT, and medical technology. It leads rounds and maintains a team of five professionals dedicated to identifying companies that can advance Lilly's drug discovery pipeline while also generating strong financial returns. In January 2025, Eli Lilly announced a landmark $500 million partnership with Andreessen Horowitz to create a new AI-focused biotech venture fund, signaling a major push into AI-driven drug development. The fund has made 84 investments and achieved an exceptional exit record of 36 exits, including 8 NASDAQ IPOs: BioAge Labs reached a $615 million market cap in September 2024, Kymeratx achieved an $863 million market cap, and Coherus Biosciences, Sutro Biopharma, and Protagonist Therapeutics have also gone public. The portfolio has also seen 19 acquisitions. Active portfolio companies include Insilico Medicine, an AI drug discovery firm that received Lilly Ventures' most recent investment in June 2025, alongside basys.ai and Evox Therapeutics. The fund also separately manages a $300 million Social Impact Venture Capital Portfolio targeting investments with measurable patient and societal benefit. Lilly Ventures operates as part of a broader Eli Lilly innovation ecosystem that includes Lilly Gateway Labs and Lilly ExploR&D, allowing portfolio companies to access laboratory infrastructure, scientific talent, and Lilly's global clinical and commercial networks. The fund's strategic alignment with Lilly's therapeutic priorities gives portfolio companies meaningful potential pathways to partnership and acquisition.

LINE Ventures was the corporate venture capital arm of Line Corporation, creator of the LINE messaging app, founded in 2014 and headquartered in Tokyo. In April 2021, following the broader merger of LINE and Yahoo Japan under Z Holdings, LINE Ventures merged with YJ Capital — Yahoo Japan's CVC — to form Z Venture Capital (ZVC). ZVC now serves as the CVC arm of LY Corporation and operates from offices in Tokyo, Seoul, and San Francisco, investing across Japan, South Korea, the United States, and Southeast Asia. The combined entity has managed approximately 185 billion yen (over $1.2 billion) in investments since 2012, with the initial LINE Ventures Global fund launched at $100 million and ZVC's 2021 fund at 30 billion yen. Under the LINE Ventures brand, the firm made 42 investments and achieved 10 exits, including 6 acquisitions. Bear Robotics was acquired by LG in January 2025, and earlier exits included Syte and iPrice. The portfolio spanned software, AI, e-commerce, fintech, gaming, healthtech, and hardware and robotics sectors. ZVC leads rounds and backs startups at seed through Series B with typical checks of $500K to $10 million. ZVC president Shinichiro Hori leads the combined organization. The firm's primary value proposition beyond capital is access to LY Corporation's massive combined user base — the LINE app and Yahoo Japan together reach hundreds of millions of users across Asia. ZVC describes this as 'Value Beyond Capital,' helping portfolio founders rapidly validate products and scale through proprietary distribution channels, making it particularly compelling for consumer-facing startups with regional ambitions.

Link Ventures is a prominent Nordic venture capital firm with a strategic focus on accelerating the energy transition and building scalable technology solutions. Specializing in early-stage investments from pre-seed to Series A, Link Ventures prioritizes sectors such as clean energy, software, mobility, and tech that drive sustainable development. Notable investments by Link Ventures include SolarDuck, an innovative player in marine technology and renewable energy, and Glint Solar, specializing in AI-driven solar energy solutions. They actively invest in startups like Vignita, focusing on B2B corporate training, and Rightcharge, enhancing automotive charging solutions. Geographically, Link Ventures has a strong presence in Nordic and European markets, aiming to support over 100 early-stage companies across Europe. Their investment strategy involves not only financial backing but also active involvement in portfolio companies through strategic support, networking, and board representation. They typically invest between €100,000 to €5M, often leading investment rounds. The team at Link Ventures is led by seasoned professionals including Elisabeth Øvstebø, Founding Partner and Investment Director, and Christian Rangen, Chairman of the Board. They are based in Norway and are recognized for their hands-on approach and commitment to creating high-impact, sustainable businesses. Startups looking to engage with Link Ventures are encouraged to approach with a clear focus on innovation and sustainability, aligning with the firm's mission to foster the next generation of technology that addresses global energy challenges​.

LionBird, founded in 2012 and based in Tel Aviv and Chicago, focuses on early-stage investments in digital health companies. The firm targets startups that are leveraging technology to innovate and improve healthcare delivery and outcomes. Their diverse portfolio includes companies such as Ovia Health, a leader in family health solutions; Marqeta, a modern card issuing platform; and Bizzabo, an event management software company. LionBird has achieved notable exits including Ovia Health and Marqeta, which underline their strategic investment approach and successful track record. LionBird recently closed its third fund at $85 million, indicating strong support from institutional investors like the Healthcare of Ontario Pension Plan (HOOPP). This fund is set to invest in 15 to 20 early-stage companies within the digital health sector, reinforcing their commitment to transforming healthcare through technology. The firm is co-founded by Edward Michael JD, Chaim Friedman, and Jonathan Friedman, who bring extensive experience and a strong network to support their portfolio companies. LionBird aims to provide more than just capital, offering strategic guidance and resources to help startups navigate the complexities of the healthcare industry and achieve market fit.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Listen Ventures, based in Chicago, is a venture capital firm dedicated to investing in consumer-focused brands. Founded in 2010, Listen Ventures operates with a unique approach by combining capital with brand strategy, creativity, and consumer insights to help entrepreneurs build impactful brands. The firm has raised $92 million across two funds: Listen Ventures III, a $62 million core fund for early-stage investments, and Listen Up, a $30 million opportunity fund for later-stage investments in its existing portfolio. Notable investments include brands like Calm, Catch Co, Dame, Factor, and Interior Define​. Listen Ventures emphasizes a concentrated investment strategy, preferring to invest larger amounts of capital and resources into fewer companies. This allows them to provide comprehensive support, including strategic and creative guidance. Their investment thesis centers on identifying shifts in cultural narratives and consumer behavior, backing brands that address these shifts effectively.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LiveOak Venture Partners, based in Austin, Texas, is a prominent venture capital firm dedicated to investing in early-stage tech and tech-enabled service companies primarily within Texas. Founded in 2012 by Krishna Srinivasan and Venu Shamapant, LiveOak has successfully positioned itself as a leading VC firm focused on nurturing Texas-based startups. The firm has raised three major funds, with the latest being a $210 million Fund III, which surpassed its initial target of $150 million. This makes it the largest Texas-focused early-stage VC fund raised in the past decade. LiveOak's investment strategy is centered on leading or co-leading seed, Series A, and occasionally pre-seed and growth-stage investments, with initial checks ranging from $500K to $10M. They focus on sectors like healthcare technology, information technology, and tech-enabled services. LiveOak's portfolio includes notable companies such as DISCO, OJO Labs, Digital Pharmacist, and Opcity. These companies have either achieved successful exits or have continued to grow under LiveOak’s guidance. The firm prides itself on being deeply involved with its portfolio companies, providing strategic advice, leveraging a vast network, and assisting in crucial hires and growth strategies. LiveOak's commitment to Texas is evident not only in its investment focus but also in its community initiatives like LiveOak Gives, which supports local non-profit organizations. This hands-on, community-oriented approach has helped LiveOak foster a thriving entrepreneurial ecosystem in Texas, contributing significantly to the region's economic growth.

LocalGlobe, founded by Robin and Saul Klein in 1999, is a leading venture capital firm based in London. The firm focuses on seed and early-stage investments, typically investing $0-1 million. LocalGlobe has built a strong reputation for supporting startups from their inception to successful Series A rounds, often within 15 to 18 months. LocalGlobe is known for its hands-on approach, leveraging a network of industry experts and mentors to help portfolio companies navigate early-stage challenges. The firm looks for founders with a strong vision and passion for their industry, prioritizing solutions that address significant real-world problems. This strategy has led to investments in some of the most transformative companies, such as fintech giants, digital banking solutions, and innovative technology firms. Their focus is primarily on the UK market, deploying about 80% of their capital locally. This commitment to nurturing local talent has solidified their position as one of the most influential seed investors in Europe. LocalGlobe's approach and strategic investments have significantly impacted the global startup ecosystem, making them a crucial player in the venture capital landscape.

Lockstep Ventures is a $50 million venture capital firm dedicated to addressing systemic racial disparities across key areas such as health, wealth, education, and workforce development. Founded with a mission of driving economic justice and generating market-rate returns, Lockstep focuses on investing in founders of color and companies that create impactful solutions for underserved communities in the U.S. Lockstep's investment philosophy, “Disparity to Prosperity,” targets businesses that tackle racial inequality through innovative approaches, particularly in telehealth, financial inclusion, and workforce development. By focusing on sectors where racial disparities are most evident, the firm aims to create scalable solutions that close economic gaps while driving profitability. The firm is co-founded by Marcus Glover, a seasoned investor and advocate for criminal justice reform. Glover’s leadership and deep commitment to social justice have positioned Lockstep Ventures as a force for transformative change, with portfolio companies advancing in sectors like fintech and telehealth. The firm also supports initiatives like Fair Chance hiring, which aims to reduce barriers to employment for formerly incarcerated individuals.

Locus Ventures is a seed-stage venture capital firm founded by alumni from Google, Facebook, and Y Combinator. The firm focuses on investing in early-stage startups with the potential to create significant impact in various industries. Notable companies in their portfolio include Meesho, an online reselling platform; Ironclad, a contract lifecycle management software; and GitLab, a prominent DevOps platform that went public in 2021. Locus Ventures primarily invests in startups within the U.S. and Asia, leveraging their extensive experience and network in Silicon Valley and beyond. Their investment strategy emphasizes close collaboration with founders, providing guidance on product development and market strategy. They are known for their hands-on approach, often leading seed rounds and participating actively in the growth of their portfolio companies. The firm is led by partners Eric Kwan, William Chan, Perry Tam, and Tommy Tsai, who bring diverse backgrounds in technology and entrepreneurship. Locus Ventures has a track record of successful exits, including acquisitions by major companies such as Stripe and Nestlé.

Loeb.nyc is a New York-based venture collective founded by Michael Loeb and Rich Vogel. Rather than functioning as a traditional VC firm, Loeb.nyc offers a unique model that pairs capital investment with deep operational support, creating what they call a "venture collective." This model allows startups to access a wide range of expert resources including marketing, design, operational support, and strategic guidance. The goal is to empower entrepreneurs to focus on scaling their businesses, while Loeb.nyc handles many of the executional challenges that often burden early-stage companies. With a focus on direct-to-consumer, fintech, health, and tech solutions, Loeb.nyc’s portfolio is diverse and designed to foster collaboration between companies. Some notable portfolio companies include Fetch Rewards, a popular mobile app that helps shoppers save money, and InsightRX, which optimizes healthcare outcomes through precision medicine. By fostering a collaborative startup ecosystem, Loeb.nyc enables its companies to share resources and best practices, enhancing their chances of success. The leadership duo of Michael Loeb and Rich Vogel brings over three decades of entrepreneurial and investment experience, having previously built billion-dollar businesses like Synapse Group. Their hands-on approach and focus on community-building make Loeb.nyc a key player in the early-stage startup ecosystem.

Lofty Ventures is a Chicago-based angel investment community and micro venture fund founded in 2014 by Christopher Deutsch and Spencer Gordon-Sand. The firm describes itself as a convergence of Chicago's best founders and resources, investing at pre-seed and seed stages in startups primarily based in the city. With a four-person team writing checks of $10,000 to $100,000, with a sweet spot of $25,000, Lofty operates at a scale designed to catalyze first rounds for nascent Chicago companies while maintaining a strong focus on supporting underrepresented founders. The firm has participated in approximately 11 tracked portfolio deals across software, SaaS, consumer goods, and healthtech sectors. The standout exit is Cubii, a maker of portable seated fitness devices, which was acquired by Gridiron Capital for a reported $100 million — the fund's most significant return to date. SHYFT Power Solutions exited in November 2024. Other portfolio companies include Gather Voices, WeCasa, UpKey, Bridge Money, Paladin, 4Degrees, Resonado, Arvist, and PairUp, the fund's most recent investment from July 2024. Beyond writing checks, Lofty runs active community programming for its portfolio, including founder dinners and the Women of Lofty initiative, reflecting the firm's emphasis on community building as a competitive advantage. While operating at angel and micro-VC scale, Lofty has carved a distinctive niche as one of Chicago's most community-oriented early-stage investment groups, helping build the city's next generation of technology companies through both capital and sustained founder relationships.

Long Journey Ventures, founded in 2019 and based in San Francisco, focuses on early-stage investments across various sectors, including enterprise applications, consumer products, and emerging technologies. The firm has built an impressive portfolio featuring notable companies like Affirm, Uber, SpaceX, and Carta. They have also invested in innovative startups such as Flexport, Grove Collaborative, and Checkr. Long Journey Ventures typically invests in seed and Series A rounds, with an average round size of $17 million. Their strategy includes both leading and participating in funding rounds, providing strategic support and leveraging their extensive network to help startups scale. The firm has successfully nurtured nine unicorns, including Together AI, Crusoe, and Density. The leadership team includes experienced professionals like Cyan Banister, Lee Jacobs, and Arielle Zuckerberg, who bring deep expertise in venture investing and a strong track record of successful exits. Long Journey Ventures has been active with recent investments in sectors like satellite communication (Northwood Space) and cloud security (LimaCharlie), highlighting their commitment to supporting groundbreaking technologies and innovative business models.

Longbow Capital is a UK-based venture capital firm that has been investing in the healthcare, life sciences, and well-being sectors since its founding in 2004. Headquartered in Norwich, the firm primarily focuses on unquoted UK companies with strong growth potential. Longbow Capital specializes in identifying investment opportunities that can deliver exceptional returns for its high-net-worth and professional clients. With a proven track record in both early and late-stage investments, Longbow is particularly interested in innovative healthcare technologies and life sciences, as well as companies that align with the growing well-being industry. The firm's portfolio includes standout companies such as Calon Cardio-Technology and Destiny Pharma, which have progressed through clinical trials and even to IPOs, reflecting Longbow’s ability to back transformative ventures. Longbow is also actively involved in fostering partnerships with innovation hubs like the Boots Centre for Innovation, a collaboration aimed at bringing cutting-edge health and well-being products to market. This initiative, based in Swansea, provides a pathway for early-stage companies and inventors to scale their products within established retail networks, ensuring greater market access. A key aspect of Longbow’s investment strategy is its focus on tax-efficient investment vehicles such as the Enterprise Investment Scheme (EIS) and Business Property Relief (BPR). These schemes offer UK investors significant tax relief on their investments, including income tax, capital gains tax, and inheritance tax benefits. This tax-efficient approach, combined with the firm's deep sector expertise, positions Longbow as a leading investor in the UK’s dynamic healthcare and life sciences landscape​.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Longevity Vision Fund (LVF) is a venture capital firm based in New York City, founded by Sergey Young. The fund focuses on investing in technologies and companies that aim to extend healthy human lifespans and address the negative effects of aging. With a $100 million fund, LVF supports innovations in preventive medicine, early detection, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. LVF's mission is to accelerate breakthroughs in longevity and make these advancements more accessible and affordable to the general public. Notable investments include Senda Biosciences, a company dedicated to developing treatments through its proprietary molecular platform. The fund is led by Sergey Young, a prominent figure in the longevity space with over 20 years of investment experience. Other key team members include Avetik Arakelyan, Sourav Sinha, and Kris Verburgh, who bring diverse expertise in healthcare, technology, and finance. LVF targets early-stage investments and partners with innovative companies worldwide, aiming to transform the life sciences and healthcare industries. They emphasize a long-term commitment to improving human health and promoting a healthier, longer life for everyone.

Longitude Capital is a healthcare-focused venture capital firm that invests across biotechnology, medical technology, and health solutions sectors. Established in 2006, the firm seeks out transformative companies that can improve clinical outcomes, enhance quality of life, and drive healthcare efficiencies. They invest across various stages, from startups to growth companies, with a unique focus on areas like oncology, neurodegenerative diseases, aging, and cardiovascular solutions. Longitude's approach is flexible, allowing them to invest in early clinical-stage companies, spin-outs, and even publicly traded firms. The firm is known for its involvement in special situations, including recapitalizations and PIPEs (Private Investment in Public Equity). They have a proven track record with successful IPOs and acquisitions, such as Aimmune Therapeutics, KaNDy Therapeutics, and Axonics Modulation Technologies. With $585 million raised in its latest fund (LVP4), Longitude Capital's strategy remains rooted in long-term value creation, bolstered by robust internal research teams. Their offices are located in Menlo Park, Greenwich, and Boston, and they continue to partner with both emerging and established healthcare innovators.

Longwall Ventures is a UK-based venture capital firm specializing in early-stage investments in the health, resilience, and sustainability sectors. Founded with a mission to support innovative startups, Longwall Ventures has a strong focus on companies that leverage science and engineering to create impactful solutions. Notable investments by Longwall Ventures include Wayland Additive, which develops advanced 3D printing technologies; Lightcast Discovery, a biotechnology firm; and Caristo Diagnostics, which focuses on cardiovascular diagnostics. The firm has also invested in Closed Loop Medicine, a company developing personalized drug and digital therapy combinations, and LettUs Grow, which specializes in vertical farming technology. Longwall Ventures is known for its hands-on approach, providing not only capital but also strategic support to its portfolio companies. With a diverse portfolio of over 40 companies, Longwall Ventures continues to play a crucial role in fostering innovation and supporting the growth of early-stage companies in the UK and beyond.

Longwood Fund, founded in 2010 and based in Boston, Massachusetts, is a venture capital firm specializing in creating and investing in science-based companies that develop novel solutions to address important medical needs. The fund's principals have co-founded 25 companies, serving as CEOs, Chief Business Officers, and lead investors, and have helped advance over 20 products to market. Longwood Fund's portfolio includes several notable companies such as Grail, which focuses on early cancer detection, and TScan Therapeutics, which develops novel T cell therapies for cancer. Other significant investments include Immunitas Therapeutics, a company using single-cell genomics to innovate in immune oncology, and Be Biopharma, which is developing engineered B cells as a new category of cellular medicines. The fund emphasizes a value-add investment approach, actively supporting its portfolio companies in accelerating clinical progress from lab to patient. With a strong track record of successful exits, including Pyxis Oncology and PTC Therapeutics, Longwood Fund continues to play a pivotal role in advancing healthcare innovations.

Longworth Venture Partners is a venture capital firm founded in 1999 by Jim Savage and Paul Margolis, based in Waltham, Massachusetts. The firm backs passionate entrepreneurs pursuing breakthrough ideas in emerging technology markets, with a track record across systems and infrastructure, business and consumer internet, and digital media. Longworth has raised three funds and typically invests $2 million to $3 million per company, though the firm is comfortable with seed commitments as low as $250,000 or growth investments up to $4 million. General Partner Nilanjana Bhowmik, who joined in 2004, and Peter Roberts round out the investment team. Atlas Venture is a frequent co-investor. The firm has invested in 55 companies across enterprise software, data analytics, retail technology, healthtech, and media sectors, primarily in the United States with selective investments in India and Israel. The portfolio has generated 1 IPO and 37 acquisitions. Notable exits include Constant Contact, the email marketing platform that went public; RapidMiner, a data science tool acquired in September 2022; Applause, an app testing platform; Hospital IQ, a healthcare operations system; and Sermo, a physician professional network. Longworth was also an early backer of GoDaddy. Other portfolio companies include Mobiquity, NuoDB, Moodlerooms, and Creative Market. Longworth leads rounds and emphasizes a partnership model that extends well beyond initial capital — helping companies navigate market positioning, hiring key executives, and building strategic relationships as they move from early traction toward category leadership. The firm's most recent investment was NuoDB in December 2018, and it appears to be in a harvest phase focused on its existing portfolio rather than making new commitments.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.

Looking Glass Capital is an early-stage venture capital firm focused on mission-driven founders addressing major global challenges in health, climate, and empowerment. Founded by Adam Besvinick, the firm typically invests in pre-seed and seed rounds, often positioning itself as the “first yes” for startups. They prioritize companies developing disruptive technologies, especially those that enhance access, self-expression, and identity. Their investments range from $300k to $500k, usually participating in funding rounds between $750k and $3 million. Looking Glass is highly involved with the startups they back, providing not just capital, but ongoing support through strategic advice, networks, and guidance. The firm is known for being hands-on, valuing strong relationships with founders, and is almost always available for consultations, aiming to be a significant early-stage partner. Their portfolio includes a variety of impactful companies, such as Daily Blends and WattCarbon, reflecting their focus on sustainable, forward-thinking sectors​.

Lool Ventures is a Tel Aviv-based early-stage venture capital firm that invests primarily in Israeli startups. Founded in 2012, the firm focuses on seed and pre-seed funding, helping ambitious entrepreneurs build innovative companies that can compete on a global scale. Lool Ventures is sector-agnostic, with investments spanning across areas such as fintech, digital health, SaaS, AI, logistics, and more, demonstrating a commitment to backing technology that transforms industries. The firm is known for its hands-on approach, partnering closely with startups to provide not just capital but also strategic guidance, mentorship, and operational support. Lool Ventures typically leads or co-leads investment rounds, and its involvement often extends from the earliest stages through Series A. The firm’s diverse portfolio includes companies like Bringg, a leading logistics platform; CyberMDX, which focuses on healthcare cybersecurity; and Zencity, a data analytics platform for local governments. Lool Ventures’ team, led by General Partners Avichay Nissenbaum and Yaniv Golan, brings a wealth of entrepreneurial experience, which helps them connect with founders and anticipate the challenges faced during the growth phase. With assets under management totaling around $200 million, Lool Ventures continues to play a significant role in Israel’s startup ecosystem, seeking out visionary founders who are ready to innovate and disrupt traditional markets.

Lorimer Ventures is a venture capital firm that specializes in investing in early-stage B2B SaaS companies. Their key focus areas include fintech, e-commerce tooling, developer tools, intelligent infrastructure, and future of work applications. They pride themselves on being highly supportive and responsive, often engaging deeply with their portfolio companies to provide strategic guidance, introductions to customers, investors, and talent, and valuable insights from their extensive network of experienced operators and executives. The team at Lorimer Ventures includes notable figures like Stephan Cizmar, a serial entrepreneur with a background in scaling B2B software companies, and Nick Wijnberg, an investor with extensive experience in finance and agribusiness. They are complemented by operating partners like Pete Schork and Zach Magdovitz, who bring expertise in sustainable energy, mobility, and product management​. Lorimer Ventures has built a diverse portfolio of innovative companies, including TakeShape, Northbeam, Polar Signals, and Capchase, among others. Their approach is to roll up their sleeves and work closely with founders to drive their businesses forward.

Loup Ventures is a Minneapolis and New York-based venture capital firm focused on frontier technologies, including artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and robotics. Founded in 2017 by Andrew Murphy, Doug Clinton, and Gene Munster, the firm invests primarily in early-stage companies that are at the intersection of these emerging technologies. Loup Ventures is research-driven, leveraging in-depth analysis and insights to guide its investment decisions. Notable investments include Neurable, an AI company advancing brain-computer interfaces, and Skupos, a platform providing data solutions for convenience stores. The firm is known for its focus on high-impact sectors like neurotechnology, and the future of transportation, with its portfolio companies aiming to shape the way humans interact with machines and the digital world. Geographically, Loup Ventures focuses on investments across the U.S., with its team frequently engaging in thought leadership through articles and podcasts on technological trends. Their investment strategy emphasizes deep involvement, supporting founders not only financially but also with insights derived from their rigorous market research. The team, led by Gene Munster, a well-known tech analyst, and Andrew Murphy, brings extensive experience in tech and finance. Loup Ventures prefers a hands-on approach, often leading rounds and staying actively involved in guiding startups to scale. Startups looking to attract their attention should highlight disruptive tech in AI or AR, showcasing robust market research and a clear vision for the future.

Love Ventures is an EIS venture capital fund founded in 2020 by brothers Marcus Love and Adrian Love, headquartered in London, United Kingdom. The firm invests from pre-seed to Series A across three core sectors: fintech, focused on modernizing financial infrastructure; future of work, covering adaptive systems and productivity software; and consumertech, targeting technologies that improve everyday life across housing, health, mobility, and commerce. Love Ventures has raised three EIS funds, with Fund II closing at £7.5 million, two of which are fully deployed. The firm invests $100,000 to $1.5 million per round and leads rounds. The founding partners bring a personal angel track record of 35% IRR, having previously backed Revolut, Chip, and Black Sheep Coffee. The portfolio of approximately 30 companies includes Tembo, the UK's leading homebuyer and savings platform, which has raised £14 million. Recent investments include Mintago, a financial wellbeing software platform (May 2025), and POCKLA (seed, March 2025). Other portfolio companies include Bourn.ai, which raised a £1.5 million seed round; By Jove! InsurTech, which raised £3.6 million at seed; Verna Earth Solutions; Just Move In; Wayhome; Fifth Dimension; and Solo. Exits include So-Sure, which was acquired by Open in March 2024, and Secret Spa. The advisory team includes individuals who have previously exited CyberSource, The Instant Group, Passmark Security, and Skyscanner. Love Ventures provides portfolio companies with hands-on support spanning product strategy, go-to-market planning, fundraising preparation, and warm introductions to investors and strategic partners. The fund also builds an engaged investor community around its portfolio, creating connections between founders and experienced operators that extend well beyond the initial capital commitment.

Low Carbon Innovation Fund (LCIF), established in 2010 and based in Norwich, United Kingdom, focuses on investments in the clean technology sector. Managed by Turquoise International, LCIF supports small and medium-sized enterprises (SMEs) in developing products and services that have a beneficial environmental impact. The fund is primarily backed by the European Regional Development Fund and targets areas including renewable energy, energy efficiency, and sustainable materials​. Notable investments include companies like Skoot, an environmental services firm; Cellexcell, specializing in advanced materials; and Advanced Electric Machines, which focuses on sustainable electrical equipment. LCIF has also made significant exits, such as the sale of companies like Syrinix, which provides smart pipeline monitoring solutions, and Breathing Buildings, a specialist in natural ventilation systems​​. LCIF is known for its collaborative investment approach, often partnering with other investors to maximize impact. Recent co-investments include contributions to Net Zero Now, a platform that helps businesses achieve and certify their net zero carbon emissions​​. This strategy aligns with their broader mission to drive innovation and support the transition to a low-carbon economy.

Lowercarbon Capital, founded in 2018 by Chris and Crystal Sacca, is a venture capital firm dedicated to combating climate change through investments in innovative technologies. Based in Jackson, Wyoming, the firm focuses on backing companies that reduce CO2 emissions, remove existing carbon from the atmosphere, and develop solutions to mitigate the impacts of climate change. Notable investments include Lilac Solutions, which is revolutionizing lithium extraction; Solugen, which produces chemicals using enzymes instead of oil; Commonwealth Fusion Systems, working on fusion energy; and Mosa Meat, creating lab-grown meat to reduce livestock emissions. Lowercarbon Capital has invested in over 160 companies, aiming to combine hard science with ambitious goals to tackle climate challenges. The firm’s strategy emphasizes both financial returns and environmental impact, supporting startups from the R&D stage to seed funding with checks ranging from $50,000 to $1 million. Their comprehensive approach includes not only capital but also strategic guidance and support for founders through a robust ecosystem of industry experts and fellow entrepreneurs​. Led by a team of experienced investors and scientists, including managing partner Chris Sacca, Lowercarbon Capital is positioned at the forefront of climate tech innovation, making significant strides in various sectors such as energy, agriculture, and industrial materials.

Lowercase Capital, founded by Chris Sacca in 2010, is a renowned venture capital firm based in San Francisco. The firm specializes in early-stage investments and has built a notable portfolio featuring some of the most successful tech startups of the past decade. Their investments include iconic companies such as Twitter, Uber, Instagram, Twilio, Stripe, and Kickstarter. These high-profile successes have helped establish Lowercase Capital as a significant player in the venture capital landscape. Lowercase Capital has made around 250 investments, spanning various industries including technology, media, and consumer products. They are particularly known for their involvement in Y Combinator companies, investing in startups like 9gag, Stripe, and Docker. The firm's strategy involves not only providing capital but also offering extensive support and guidance to their portfolio companies, leveraging Chris Sacca's extensive experience and network within the tech industry. The firm's notable exits include Slack, Instagram, and Twitter, which have contributed significantly to Lowercase Capital's reputation and financial success. These exits highlight the firm's ability to identify and nurture companies with substantial growth potential. Lowercase Capital is also known for its philanthropic efforts, supporting startups that empower and help people in need, such as charity: water and the Anti-Recidivism Coalition. Chris Sacca, the founder, has been recognized for his impactful contributions to both the business and philanthropic sectors, making him a prominent figure in the venture capital community.

Loyal VC is a global venture fund established in 2018 that operates a startup index fund with over 350 investments across more than 60 countries. The firm is known for its unique gate-stage investment process, which reduces systemic bias and aims to unlock greater returns. This process involves multiple rounds of diligence and quarterly redemptions, offering flexibility to high-net-worth individuals and institutions. Loyal VC collaborates closely with INSEAD, Founder Institute, and a network of over 1,000 advisors. This extensive network supports a diverse portfolio of founders, with more than 30% of the portfolio companies led by women CEOs and nearly 30% based in emerging markets. The firm places a strong emphasis on social impact, with 80% of its investments aligned with one or more of the UN Sustainable Development Goals (SDGs). Notable investments by Loyal VC include Sama, a company that brings transparency and verifiability to cross-border blue-collar recruitment, and TechStyle, a digital marketplace for sustainable material sourcing in the fashion industry. The firm also supports companies like CurieMD, a telemedicine platform for menopause care, and Milestone, a financial literacy app aimed at helping parents raise financially responsible children. Loyal VC’s investment focus spans various sectors, including cleantech, fintech, healthcare, and more, reflecting their commitment to backing innovative solutions across the globe. For more information, you can visit their official website.

Ludlow Ventures, founded in 2009 and based in Detroit, Michigan, is a venture capital firm that takes a unique approach to investing by emphasizing strong personal relationships with entrepreneurs. The firm focuses on early-stage investments, particularly in the technology sector. Ludlow Ventures has built a robust portfolio, with notable companies such as Honey, a browser extension for online shopping deals acquired by PayPal; Wag, a dog-walking service; and Product Hunt, a platform for discovering new products. The firm has made over 160 investments and has achieved 24 exits, showcasing their ability to identify and support high-potential startups. Other significant investments include Headout, an on-demand mobile platform for booking tours and activities, and CoverTree, an insurtech company focused on property insurance. Ludlow Ventures operates with a philosophy of "VC without ego," striving to be collaborative and supportive partners to their portfolio companies. The team, led by Managing Partner Jonathon Triest, prides itself on being deeply involved in the success of the startups they back, providing not just capital but also strategic advice and resources.

Luge Capital is a venture capital firm based in Montreal, focused on fintech and AI solutions for financial services. Founded in 2018 by David Nault and Karim Gillani, Luge Capital specializes in early-stage investments, typically at the Seed and Series A stages, providing crucial support to startups reshaping how financial services are delivered. Their investments emphasize innovation in areas like payments, digital banking, and insurtech. The fund has raised over $71 million in its second close and aims to reach $100 million to continue backing fintech companies in both Canada and the U.S. Notable investments include companies like Flinks, which was acquired by National Bank, Plooto, and Owl.co. Luge seeks founders with bold ideas and a global vision, particularly those challenging traditional finance models with scalable technology. Luge Capital prides itself on being a hands-on partner, leveraging its strong network of financial institutions like Desjardins and CDPQ to provide portfolio companies with strategic guidance, customer access, and industry insights. The firm’s team has over 50 years of collective experience as founders, operators, and investors, making them a trusted resource for startups navigating the complexities of financial technology. For entrepreneurs, Luge is a valuable partner, offering not just capital, but also the deep operational expertise and networks needed to scale. Founders looking to work with Luge should have a clear, ambitious plan for disrupting the financial landscape.

Lukkap Venture Lab is a Madrid-based startup accelerator and venture capital firm founded in 2009, operating across Madrid and Barcelona, Spain. The firm combines consulting expertise with early-stage investment, targeting startups that have already developed a product with demonstrated market fit and a pre-money valuation of approximately €4 million or less. Lukkap invests up to €150,000 in early-stage rounds and operates across all industries with the exception of crypto and web3. The firm leads investments and structures its support around four pillars: capital, sector consulting, acceleration services covering HR and operational infrastructure, and network involvement connecting startups to Lukkap's corporate client base. Lukkap has made approximately 10 investments. Named portfolio companies include FoodieFame, a food-tech platform building food brands with content creators that raised an €800,000 round co-led by Lukkap in July 2025; Tendios, an AI-powered platform for public and private procurement that raised €2 million in May 2025; Médizin, a clinical services company; and Cuimo, Olivi, CUBRO Design, Extrable, Gourmeats, and RunnerPro. The firm helps portfolio companies identify and attract additional investors to complete their financing needs beyond the Lukkap check. The partnership team brings complementary backgrounds: one partner has 30 years of experience at firms including McKinsey, Delta Partners, and GBL Investrategy, while another brings 15 years of angel investing and experience as founder and CEO of El Tenedor by TheFork, the restaurant booking platform. This combination of management consulting rigor and operator experience gives Lukkap a distinctive positioning as a hands-on institutional first check in the Spanish early-stage ecosystem.

Lumen Ventures is a Rome-based early-stage venture capital firm that focuses on investing in technology-driven startups, particularly at the seed stage. Established as the first Simple Investment Company (SiS) in Italy, Lumen Ventures manages a €25 million fund aimed at backing high-potential tech startups across sectors like fintech, insurtech, healthtech, and foodtech. Lumen Ventures differentiates itself by being led by a team of former entrepreneurs and operators, which gives them a practical understanding of the challenges faced by startups. This experience enables them to provide not only financial support but also strategic guidance to help founders scale their businesses both in Italy and across Europe. The firm typically invests between €100,000 and €1.5 million per company and is particularly keen on supporting second-time founders. By leveraging their industry expertise and entrepreneurial background, the Lumen Ventures team is committed to helping startups build sustainable growth pathways.

Luminar Ventures is a Stockholm-based pre-seed and seed-stage venture capital fund founded in 2017 by serial entrepreneurs and experienced angel investors Magnus Bergman and Jacob Key, together with Sting, Sweden's leading startup platform. Bergman has made 30 or more seed investments, while Key's prior angel portfolio includes Challengermode, Unacast, and FirstVet. Partner Linda Hoglund joined with the second fund. Luminar manages over €130 million across two funds: Fund I at approximately €60 million and Fund II at $65 million (final close in 2023). The firm leads seed rounds and invests €500,000 to €2.5 million per deal, averaging roughly €1 million per investment, with smaller pre-seed bets and occasional larger late-seed commitments. Luminar focuses on scalable digital seed-stage companies from the Nordics, investing across software, SaaS, healthtech, AI, clean energy, and security sectors. As of 2025, the portfolio comprises 43 companies with 5 new investments in the preceding 12 months. Recent investments include Photoncycle in alternative energy (March 2026), IPercept, Corsmed (a $3.5 million health tech seed), Lightbringer (a €4.2 million legal tech round co-led with Alliance VC), and Motorica (a €5 million animation technology seed). The fund has 4 portfolio exits including Muninn in October 2024 and Debricked, which was acquired. Luminar's founding model — pairing professional VC structure with the operating experience of repeat entrepreneurs — reflects a deliberate view that the best seed investors have built companies themselves. The firm concentrates on highly motivated founders with a clear vision to disrupt major industries, offering not just capital but the pattern recognition that comes from the partners' own time building and scaling Nordic technology businesses.

Luminous Ventures is a London-based early-stage deep tech venture capital fund that spun out of White Cloud Capital in December 2018 with a $30 million fund. The firm focuses on the application of innovative technologies to healthcare, life sciences, nutrition, food, and agriculture, investing at seed and Series A stages across Europe and North America. Luminous prefers to be the first venture investor in its portfolio companies, backing visionary founders with scientifically grounded breakthroughs at the earliest stages of company formation. Partner Izzy Fox leads the investment team. The fund is now fully deployed and is no longer making new investments. The portfolio of approximately 27 companies spans healthtech, AI, biotech, and food and agriculture. Named portfolio companies include Astroscreen (disinformation detection), Ellipsis Health (mental health voice AI), Hadean (high-performance cloud operating systems), Optellum (AI-based lung cancer diagnostics), Synthace (lab operating systems), Universal Quantum (quantum computing), OVR Health (VR health applications), Vital Bio (point-of-care diagnostics), and Facesoft (sustainable textile face coverings). BioBeats, an earlier portfolio company, was acquired by Huma in April 2020. The fund's most recent investment was Treos Bio in April 2024. Luminous Ventures' thesis was built on the convergence of computational power, biological understanding, and materials science — investing ahead of when these disciplines became mainstream VC themes. The firm prioritized backing founders with credible scientific backgrounds working on problems where technology could fundamentally change outcomes in health and food systems, rather than incremental software applications at the margins of these sectors.

Lumira Ventures is a prominent venture capital firm specializing in life sciences and healthcare investments. Established in 1989 and headquartered in Toronto, Canada, Lumira Ventures has a robust presence across North America, with offices in Toronto, Montreal, Vancouver, and Boston. The firm focuses on backing innovative biotechnology and medical technology companies that have the potential to address significant unmet medical needs and improve healthcare quality globally. The firm's investment portfolio includes a wide range of companies such as Depomed, Guava Technologies, Think Research, and U-Systems, showcasing their diverse interest in biopharmaceuticals and medical devices. Notable recent investments include Antiva Biosciences, developing topical therapies for HPV-related pre-cancerous lesions, and Arclight Therapeutics, focusing on neurodegenerative diseases. Lumira Ventures' investment strategy involves providing substantial support to their portfolio companies, from early-stage funding to strategic guidance. They recently closed their Lumira Ventures IV fund at $220 million, the largest life sciences venture fund ever raised in Canada, highlighting their significant role in the sector. Overall, Lumira Ventures is dedicated to advancing healthcare innovation through strategic investments and active support of pioneering companies in the life sciences domain.

LUMO Labs is a dynamic venture capital firm based in Eindhoven, Netherlands, that prioritizes impact-driven investments in emerging digital technologies. Focused on pre-seed to Series A stages, LUMO Labs targets startups in fields like AI, blockchain, robotics, IoT, and AR/VR. The firm is deeply committed to supporting innovations that address global challenges related to sustainable cities, health, well-being, and education. Its portfolio includes companies such as Alphabeats, Enliven, and Roboat, all of which push the boundaries of technology while contributing to societal progress. Founded by Andy Lürling and Sven Bakkes, LUMO Labs has gained recognition for its hands-on approach. Startups in their portfolio benefit from a two-year venture builder program, which provides personalized coaching, access to expert networks, and support tailored to each company's unique needs. This program focuses on four key pillars: leadership, product-market fit, storytelling, and follow-on investment, ensuring that startups scale effectively both economically and socially. With the recent launch of the €100 million LUMO Rise Fund, LUMO Labs has expanded its scope across Europe, investing in climate action, digital security, and projects aligned with the UN’s Sustainable Development Goals. LUMO Labs is driven by the belief that technological advancements can serve as powerful tools for creating a better and more sustainable future.

Lunar Ventures is a Berlin-based venture capital firm focused on investing in deep-tech startups across Europe. The firm specializes in early-stage companies, often leading seed rounds with investments ranging from €300K to €1M. Lunar Ventures primarily targets highly technical founders working on breakthrough innovations in fields like artificial intelligence, cryptography, cloud infrastructure, and advanced computing. Their mission is to support visionary entrepreneurs building cutting-edge technologies that address complex, global challenges. What sets Lunar Ventures apart is their deep technical expertise. The team comprises engineers, computer scientists, and tech-bio specialists who provide hands-on support to portfolio companies. This background enables them to understand and back startups tackling the most complex technical problems, often before they generate revenue. The firm is committed to helping these companies scale, offering both financial capital and strategic guidance throughout their development journey. Lunar’s portfolio reflects its commitment to innovation, featuring companies such as Zama, which focuses on privacy-preserving AI, and Bedrock, which is revolutionizing ocean floor mapping with autonomous underwater vehicles. Lunar’s approach to investing emphasizes a long-term vision, partnering with startups from seed to Series A and beyond, helping them navigate the challenges of growth in the deep-tech ecosystem. Based in Berlin, Lunar Ventures operates across Europe, working with companies that are redefining industries through science and engineering, and making an impact in sectors ranging from AI to biotech and beyond.